Results

Total Results: 1,528 records

Showing results for "drugs".

341. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
     March 01, 2012 - Relative medication adherence and persistence with drug therapy across the different classes of drugs … Relative medication adherence and persistence with drug therapy across the different classes of drugs … Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis. … Am J Cardiovasc Drugs 8 (#date#) 35-44 Vijan S. 2009. Diabetes: treating hypertension. … First-line drugs for hypertension.

342. Off-Label Use of Atypical Antipsychotics: An Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/atypical-antipsychotics-off-label-update/research

343. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Current treatments for OA include over-the-counter analgesics and nonsteroidal anti-inflammatory drugs

344. Treatment of Hepatitis C Virus Infection in Adults: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
     April 01, 2013 - • How does the efficacy of antiviral drugs change with lower treatment adherence? … Pharmaceuticals. … and “How does the efficacy of antiviral drugs change with lower treatment adherence?” Table 5. … How does efficacy of antiviral drugs change with lower treatment adherence? … Pharmaceuticals.

345. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/vte-prophyalaxis_research-protocol.pdf
     March 01, 2011 - Pharmacologic Agents and Medical Devices Used for Thromboprophylaxis There are a number of antithrombotic drugs … We will evaluate drugs and devices that currently are available in the United States and either are … optimal choice of therapy among burn centers. 17 There is considerable uncertainty around specific drugs … of pharmacologic prophylaxis among patients at the extremes of weight and will assess the optimal drugs … Ballerup, Denmark: LEO Pharmaceutical Products; 2008.

346. Topic 0549 Diagnosis and Management of Gout NSD _SJ Clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0648-140819.pdf
     June 24, 2014 - interventions (e.g., dietary therapies) and pharmacotherapeutics (e.g., non-steroidal anti-inflammatory drugs

347. Crosscutting-Horizon-Scan-High-Impact-1512 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Results The table below lists four topics for which (1) preliminary phase III data for drugs were … Now, Proteus is collaborating with Otsuka Pharmaceuticals Co., Ltd. … It differentiated 100% of multiple drugs and doses taken simultaneously by type and by dose. … Proteus is collaborating with Otsuka Pharmaceuticals Co., Ltd., (Tokyo, Japan) to integrate sensors

348. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the

349. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1306.pdf
     June 11, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the

350. S23 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s23.pdf
     October 01, 2007 - Relative Risk, Number Needed to Harm, Frequency Information, and Public Health Impact for Selected Drugs … Drug Discovery, Development, and Translation Work- shop 2: Understanding the Benefits and Risks of Pharmaceuticals … Yale Study Parks FDA Review of Cold Drugs. The Yale Herald News Online 2000. … Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia:

351. Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-standardized-library.pdf
     February 01, 2019 - https://www.fda.gov/AboutFDA/CentersOffices/Offi ceofMedicalProductsandTobacco/CDRH/ CDER monitors drugs … Also, efforts to combine drugs (e.g., adding antipsychotic to antidepressant). … Several novel drugs are being studied in trials currently. … for more than $20 billion in direct and indirect expenses each year in the US§§ Treated with pharmaceuticals … Antidepressants Anti-seizure drugs Botox Alternative medicine, including acupuncture, biofeedback

352. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Autism treatments and drugs. [internet].

353. Use of Observational Studies in Systematic Reviews of (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
     June 01, 2010 - patients to be new users of the specific cohort-defining drug or new users of the entire class of drugs … biased observational studies require all patients in the cohort to be new users of the entire class of drugs … Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach. … Drug class review: atypical antipsychotic drugs, Final report update 2. In: Helfand M, ed. … patients with schizophrenia initiating treatment with an atypical antipsychotic medication, which drugs

354. Use of Observational Studies in Systematic Reviews of (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguidenorris_060420101.pdf
     June 01, 2010 - patients to be new users of the specific cohort-defining drug or new users of the entire class of drugs … biased observational studies require all patients in the cohort to be new users of the entire class of drugs … Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach. … Drug class review: atypical antipsychotic drugs, Final report update 2. In: Helfand M, ed. … patients with schizophrenia initiating treatment with an atypical antipsychotic medication, which drugs

355. Data-Points-9 Maps (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/data-points-9_maps.pdf
     May 29, 2025 - Utilization of Sulfonylureas per 100 Diabetic Medicare Beneficiaries With Continuous Enrollment in Parts A and B FFS and Part D, by Hospital Referral Region (HRR), 2006-2009 Annual Utilization of Sulfonylureas Among Diabetic Beneficiaries With At Least One Antidiabetic Drug Order, by HRR, 2006 Annual Util…

356. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
     January 10, 2012 - approaches to psoriasis treatment. 4,5,11 Biologic therapies for psoriasis use genetically engineered drugs … systemic therapy or phototherapy Etanercept Enbrel ® (injectable) Amgen, Inc. and Wyeth Pharmaceuticals … (Schwarz Pharma Manufacturing; OSI Pharmaceuticals Inc.) … Teva Pharmaceuticals USA (Barr Pharmaceuticals) Symptomatic control of severe, recalcitrant, … oral capsule) GlaxoSmithKline (CatalentPharmaSo lutions;Accucaps Industries, Ltd.; Banner Pharmaceuticals

357. Calcineurin_Inhibitors_Protocol_FINAL_10-07-2014 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
     October 08, 2014 - amount of drug administered early or late post- transplant; 4) CNI avoidance, which substitutes other drugs … Safety of immunosuppressive drugs used as maintenance therapy in kidney transplantation: a systematic … Pharmaceuticals. 2013;6(10):1170-94. Also available: http://dx.doi.org/10.3390/ph6101170. … relies on antibodies binding to specific antigens; frequently used to measure levels of therapeutic drugs … in a biologic sample Nephrotoxicity: exposure of the kidneys to poisonous (toxic) chemicals; many drugs

358. Medication-Therapy-Management Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdf
     January 01, 2014 - programs target Medicare Part D enrollees, who have multiple chronic diseases, are taking multiple Part D drugs … , and are likely to incur annual costs for covered Part D drugs that exceed a predetermined level (“ … A plan may require no more than eight Part D drugs, although they may set at the maximum at any number … personal medication report, which is a written list of the patient’s prescription and nonprescription drugs … Drugs. 2009;69(4):393-406. PMID: 19323584. 3. Lewin Group.

359. CER 173 Executive Summary: Diabetes Medications for Adults With Type 2 Diabetes: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
     January 01, 2015 - medications have also emerged, which could change the balance of benefit and risk attributable to these drugs … While we did not combine studies in which individual drugs were found to be a clinical or statistical … Takeda Pharmaceuticals America. … Incretin mimetic drugs for type 2 diabetes: early communication - reports of possible increased risk … www.fda.gov/Drugs/DrugSafety/ucm446845.htm. Accessed July 25, 2015. 72.

360. Identification and Treatment of Post-Acute Coronary Syndrome (ACS) Depression: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-depression-research-protocol-amended.pdf
     February 15, 2017 - Appendix A: FDA Status and Warnings for Drugs … Vintage Pharmaceuticals,LLC, Huntsville, AL, 2006. 9. … Teva Pharmaceuticals USA, Inc. (per FDA), Horsham, PA, 2014. 19.